Literature DB >> 12967154

The asbestos war.

Laurie Kazan-Allen1.   

Abstract

That asbestos is still being sold despite overwhelming evidence linking it to debilitating and fatal diseases is testament to the effectiveness of a campaign, spear-headed by Canadian interests, to promote a product already banned in many developed countries. Blessed by government and commercial support, asbestos apologists have implemented a long-term coordinated strategy targeting new consumers in Asia, the Far East and Latin America. At industry-backed "conferences" and on government-funded junkets, they spin a web of deceit, telling all who will listen that "chrysotile (white asbestos) can be used safely." The fact that Canada exports over 95% of all the chrysotile it mines suggests that while chrysotile is supposedly safe enough for foreigners, it is not safe enough for Canadians. Asbestos victims in many countries have struggled to gain public recognition of the human cost of asbestos use. In recent years, nongovernmental organizations working with these groups have created a global anti-asbestos virtual network; with the commitment and support of thousands of "virtual members," this network challenges industry's propaganda and exposes the forces that support its cynical attempt to offload this dangerous substance on developing countries.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12967154     DOI: 10.1179/oeh.2003.9.3.173

Source DB:  PubMed          Journal:  Int J Occup Environ Health        ISSN: 1077-3525


  8 in total

1.  Asbestos Surveillance Program Aachen (ASPA): initial results from baseline screening for lung cancer in asbestos-exposed high-risk individuals using low-dose multidetector-row CT.

Authors:  Marco Das; Georg Mühlenbruch; Andreas H Mahnken; K G Hering; H Sirbu; W Zschiesche; Lars Knoll; Michael K Felten; Thomas Kraus; Rolf W Günther; Joachim E Wildberger
Journal:  Eur Radiol       Date:  2006-09-20       Impact factor: 5.315

2.  The case for a global ban on asbestos.

Authors:  Joseph LaDou; Barry Castleman; Arthur Frank; Michael Gochfeld; Morris Greenberg; James Huff; Tushar Kant Joshi; Philip J Landrigan; Richard Lemen; Jonny Myers; Morando Soffritti; Colin L Soskolne; Ken Takahashi; Daniel Teitelbaum; Benedetto Terracini; Andrew Watterson
Journal:  Environ Health Perspect       Date:  2010-06-08       Impact factor: 9.031

3.  A 26-year-old male with mesothelioma due to asbestos exposure.

Authors:  P Zarogoulidis; M Orfanidis; T C Constadinidis; E Eleutheriadou; T Kontakiotis; T Kerenidi; L Sakkas; N Courcoutsakis; K Zarogoulidis
Journal:  Case Rep Med       Date:  2011-07-12

4.  Global health: chronic diseases and other emergent issues in global health.

Authors:  Tracey Pérez Koehlmoos; Shahela Anwar; Alejandro Cravioto
Journal:  Infect Dis Clin North Am       Date:  2011-09       Impact factor: 5.982

5.  The asbestos cancer epidemic.

Authors:  Joseph LaDou
Journal:  Environ Health Perspect       Date:  2004-03       Impact factor: 9.031

Review 6.  Evidence for Health II: Overcoming barriers to using evidence in policy and practice.

Authors:  Anne Andermann; Tikki Pang; John N Newton; Adrian Davis; Ulysses Panisset
Journal:  Health Res Policy Syst       Date:  2016-03-14

Review 7.  Asbestos-Related Disorders in Germany: Background, Politics, Incidence, Diagnostics and Compensation.

Authors:  Xaver Baur
Journal:  Int J Environ Res Public Health       Date:  2018-01-16       Impact factor: 3.390

8.  Ongoing downplaying of the carcinogenicity of chrysotile asbestos by vested interests.

Authors:  Xaver Baur; Arthur L Frank
Journal:  J Occup Med Toxicol       Date:  2021-02-23       Impact factor: 2.646

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.